Anti-TNF alpha in the treatment of psoriatic arthritis

被引：5
|
作者：
Claudepierre, P
Wendling, D
Cohen, JD
机构：
[1] CHU Henri Mondor, Serv Rhumatol, F-94010 Creteil, France
[2] CHU Jean Mindoz, Serv Rhumatol, Besancon, France
来源：
PRESSE MEDICALE | 2006年 / 35卷 / 04期
关键词：
D O I：
10.1016/S0755-4982(06)74658-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Psoriatic arthritis is on inflammatory and possibly destructive form of arthritis. As in rheumatoid arthritis and ankylosing spondylitis, the use of biological therapy in psoriatic arthritis is a therapeutic revolution: both articular and cutaneous efficacy have been shown, and some improvement is visible on radiography. The benefit-risk ratio will improve when we learn to identify more accurately the patients likely to benefit from these treatments.
引用
收藏
页码：647 / 655
页数：9
相关论文
共 50 条
  • [31] Neuromyelitis optica phenotype associated with anti-TNF therapy in psoriatic arthritis
    Boaventura, M.
    Apostolos Pereira, S.
    Rimkus, C.
    Sato, D.
    Callegaro, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 693 - 693
  • [32] PERSISTENCE ON TREATMENT AND OPTIMIZATION AMONG ANTI-TNFα AGENTS IN PSORIATIC ARTHRITIS PATIENTS IN CLINICAL PRACTICE
    Pinto-Tasende, J.
    Alonso, E.
    Bejerano, C.
    Gromaz, J.
    Acasuso, B.
    Fernandez-Lopez, C.
    Oreiro, N.
    Acasuso, M.
    De Toro, J.
    Blanco, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1154 - 1155
  • [33] TRAF3: A potential biomarker of anti-TNF treatment response in rheumatoid and psoriatic arthritis
    Xiu, Yan
    Ritchlin, Christopher
    Xing, Lianping
    Boyce, Brendan
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [34] Responsiveness Of Health Related Quality Of Life Questionnaires To Treatment With Anti-TNF Therapy In Psoriatic Arthritis
    Touma, Zahi
    Thavaneswaran, Arane
    Chandran, Vinod
    Gladman, Dafna D.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S660 - S660
  • [35] Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis
    Karadag, Omer
    Dalkilic, Ediz
    Onat, Ahmet Mesut
    Kucuksahin, Orhan
    Kasifoglu, Timucin
    Kisacik, Bunyamin
    Pamuk, Omer Nuri
    Yilmaz, Neslihan
    Koca, Suleyman Serdar
    Yazisiz, Veli
    Ocakci, Pinar Talu
    Sayarlioglu, Mehmet
    Terzioglu, Ender
    Erten, Sukran
    Oksuz, Mustafa Ferhat
    Kalyoncu, Umut
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [36] Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment
    Chimenti, M. S.
    Perricone, C.
    Graceffa, D.
    Di Muzio, G.
    Ballanti, E.
    Guarino, M. D.
    Conigliaro, P.
    Greco, E.
    Kroegler, B.
    Perricone, R.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : 23 - 30
  • [37] Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis (vol 5, pg 1491, 2005)
    Mease
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (12) : 1669 - 1669
  • [38] METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Deyab, G.
    Hokstad, I.
    Smastuen, M. C.
    Agewall, S.
    Hollan, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 704 - 704
  • [39] Anti-TNF alpha
    Faure, Sebastien
    [J]. ACTUALITES PHARMACEUTIQUES, 2010, 49 (500): : 51 - 54
  • [40] Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors
    Ballanti, Eleonora
    Perricone, Carlo
    di Muzio, Gioia
    Kroegler, Barbara
    Chimenti, Maria Sole
    Graceffa, Dario
    Perricone, Roberto
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (10) : 617 - 623
12345